These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24533459)

  • 1. A novel heterozygous SETX mutation in a patient presenting with chorea and motor neuron disease.
    Saracchi E; Castelli M; Bassi MT; Brighina E; Cereda D; Marzorati L; Patassini M; Appollonio I; Ferrarese C; Brighina L
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):138-40. PubMed ID: 24533459
    [No Abstract]   [Full Text] [Related]  

  • 2. A new SETX mutation producing AOA2 in two siblings.
    Datta N; Hohler A
    Int J Neurosci; 2013 Sep; 123(9):670-3. PubMed ID: 23566282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy.
    Rudnik-Schöneborn S; Arning L; Epplen JT; Zerres K
    Neuromuscul Disord; 2012 Mar; 22(3):258-62. PubMed ID: 22088787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal cord: motor neuron diseases.
    Rezania K; Roos RP
    Neurol Clin; 2013 Feb; 31(1):219-39. PubMed ID: 23186902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases.
    Arning L; Epplen JT; Rahikkala E; Hendrich C; Ludolph AC; Sperfeld AD
    Neurogenetics; 2013 Feb; 14(1):53-61. PubMed ID: 23129421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation (K317M) in the MAPT gene causes FTDP and motor neuron disease.
    Zarranz JJ; Ferrer I; Lezcano E; Forcadas MI; Eizaguirre B; Atarés B; Puig B; Gómez-Esteban JC; Fernández-Maiztegui C; Rouco I; Pérez-Concha T; Fernández M; Rodríguez O; Rodríguez-Martínez AB; de Pancorbo MM; Pastor P; Pérez-Tur J
    Neurology; 2005 May; 64(9):1578-85. PubMed ID: 15883319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SETX gene novel mutations in a non-French Canadian with ataxia-oculomotor apraxia type 2.
    Ghrooda S; Borys A; Spriggs E; Hegde M; Mhanni A
    Parkinsonism Relat Disord; 2012 Jun; 18(5):700-1. PubMed ID: 22341623
    [No Abstract]   [Full Text] [Related]  

  • 8. Chorea-acanthocytosis presenting as motor neuron disease.
    Neutel D; Miltenberger-Miltenyi G; Silva I; de Carvalho M
    Muscle Nerve; 2012 Feb; 45(2):293-5. PubMed ID: 22246890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis, short stature in benign hereditary chorea: a novel thyroid transcription factor-1 mutation.
    Glik A; Vuillaume I; Devos D; Inzelberg R
    Mov Disord; 2008 Sep; 23(12):1744-7. PubMed ID: 18661567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation.
    Meyer T; Jurkat-Rott K; Huebner A; Lehmann-Horn F; Linke P; Van Landeghem F; Dullinger JS; Spuler S
    Muscle Nerve; 2008 Jan; 37(1):120-4. PubMed ID: 17587224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive ataxia with peripheral neuropathy and elevated AFP: novel mutations in SETX.
    Asaka T; Yokoji H; Ito J; Yamaguchi K; Matsushima A
    Neurology; 2006 May; 66(10):1580-1. PubMed ID: 16717225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexisting amyotrophic lateral sclerosis and chorea: A case report and literature review.
    Zhang A; Xu H; Huang J; Gong H; Guo S; Lei X; He D
    Medicine (Baltimore); 2022 Dec; 101(52):e32452. PubMed ID: 36596053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset neurodegenerative disease of the cerebellum and motor axons.
    Salman MS; Marles SL; Booth FA; Del Bigio MR
    Pediatr Neurol; 2009 May; 40(5):365-70. PubMed ID: 19380073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ataxia with oculomotor apraxia type 2: novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein.
    Bernard V; Stricker S; Kreuz F; Minnerop M; Gillessen-Kaesbach G; Zühlke C
    Neuropediatrics; 2008 Dec; 39(6):347-50. PubMed ID: 19569000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An AOA2 patient with a novel compound heterozygous SETX frame shift mutations.
    Motokura E; Yamashita T; Takahashi Y; Tsunoda K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Hashiguchi A; Takashima H; Abe K
    J Neurol Sci; 2017 Jan; 372():294-296. PubMed ID: 28017231
    [No Abstract]   [Full Text] [Related]  

  • 16. Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease.
    Le Ber I; Camuzat A; Berger E; Hannequin D; Laquerrière A; Golfier V; Seilhean D; Viennet G; Couratier P; Verpillat P; Heath S; Camu W; Martinaud O; Lacomblez L; Vercelletto M; Salachas F; Sellal F; Didic M; Thomas-Anterion C; Puel M; Michel BF; Besse C; Duyckaerts C; Meininger V; Campion D; Dubois B; Brice A;
    Neurology; 2009 May; 72(19):1669-76. PubMed ID: 19433740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chorea-acanthocytosis: clinical and genetic findings in three families from the Arabian peninsula.
    Bohlega S; Al-Jishi A; Dobson-Stone C; Rampoldi L; Saha P; Murad H; Kareem A; Roberts G; Monaco AP
    Mov Disord; 2003 Apr; 18(4):403-7. PubMed ID: 12671946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.
    Tazir M; Ali-Pacha L; M'Zahem A; Delaunoy JP; Fritsch M; Nouioua S; Benhassine T; Assami S; Grid D; Vallat JM; Hamri A; Koenig M
    J Neurol Sci; 2009 Mar; 278(1-2):77-81. PubMed ID: 19141356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease.
    Chen YZ; Hashemi SH; Anderson SK; Huang Y; Moreira MC; Lynch DR; Glass IA; Chance PF; Bennett CL
    Neurobiol Dis; 2006 Jul; 23(1):97-108. PubMed ID: 16644229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents.
    Vantaggiato C; Cantoni O; Guidarelli A; Romaniello R; Citterio A; Arrigoni F; Doneda C; Castelli M; Airoldi G; Bresolin N; Borgatti R; Bassi MT
    Brain Dev; 2014 Sep; 36(8):682-9. PubMed ID: 24183476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.